Health Condition 1: L811- Chloasma
Conditions
Interventions
Intervention1: 35 percent Glycolic acid peel: The intervention agent in this study is Glycolic Acid 35 percent (w/v) peel, an Alpha Hydroxy Acid (AHA) chemical peel administered every two weeks under
Sponsors
Dr Shashikumar B M
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with melasma. Patients aged 18-65 years of both sexes. Patients who are not on active treatment and not taken any treatment for melasma in the past 1 month. Patients willing to give informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: Pregnant and lactating females. Hypersensitivity to the peeling agent. Skin infection at the site of Melasma (herpes, pyoderma, and folliculitis). Patients with topical steroid damaged face. Patients with rosacea, systemic lupus erythematosus and other photodermatoses. Patients consuming Oral contraceptive pills. Patients with unrealistic expectations. Patients consuming Isotretinoin tablets and other drug which can cause and exuberate melasma. History of keloids or hypertrophic scars. Concomitant skin or systemic disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| •Change in MASI (Melasma Area and Severity Index) score.Timepoint: •From baseline( Day 0) to 4, 8, and 12 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Grading of subjective improvement in pigmentation, assessed as no response, mild, moderate, good, or very good response based on MASI score reduction.Timepoint: Before treatment and at the completion of the study (end of 12 weeks, after the sixth peel/last follow-up visit) | — |
Countries
India
Contacts
Public ContactDr Deepadarshan K
Mandya institute of medical sciences
Outcome results
None listed